Collagen scaffolds
US-2015367030-A1 · Dec 24, 2015 · US
US9636435B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9636435-B2 |
| Application number | US-201113177720-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 7, 2011 |
| Priority date | Jul 8, 2010 |
| Publication date | May 2, 2017 |
| Grant date | May 2, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Methods for shaping tissue matrices are provided. The methods can be used to produce shaped tissue products that retain desired biologic properties without using chemical crosslinking agents.
Opening claim text (preview).
What is claimed is: 1. A method for shaping a tissue matrix, comprising: selecting a collagen-containing tissue matrix; partially dehydrating the tissue matrix; applying mechanical forces to the tissue matrix to change the orientation of collagen fibers within the tissue matrix; and exposing the tissue matrix while partially dehydrated to ionizing radiation to cross-link at least a portion of the tissue matrix. 2. The method of claim 1 , wherein the tissue matrix is an a cellular tissue matrix. 3. The method of claim 1 , wherein the tissue matrix comprises a dermal tissue matrix. 4. The method of claim 1 , wherein the tissue is selected from fascia, pericardial tissue, dura, umbilical cord tissue, placental tissue, cardiac valve tissue, ligament tissue, tendon tissue, arterial tissue, venous tissue, neural connective tissue, urinary bladder tissue, ureter tissue, and intestinal tissue. 5. The method of claim 1 , wherein partially dehydrating the tissue matrix includes removing water to produce a tissue matrix containing between 95% (w/w) and 50% (w/w) water content. 6. The method of claim 5 , wherein the water content is between 80% (w/w) and 65% (w/w). 7. The method of claim 1 , further comprising rehydrating the tissue matrix. 8. The method of claim 1 , wherein the radiation is applied at a dose between 5 Gy and 50 kGy. 9. The method of claim 1 , wherein the radiation is applied at a dose between 5 Gy and 20 kGy. 10. The method of claim 1 , wherein the radiation is applied at a dose of less than 10 kGy. 11. The method of claim 1 , wherein the radiation is applied at a dose of less than 5 kGy. 12. The method of claim 1 , wherein the radiation is applied at a dose of less than 1 kGy. 13. The method of claim 1 , wherein the radiation is selected from gamma radiation, e-beam radiation, and X-ray radiation. 14. The method of claim 1 or 2 , wherein selecting a tissue matrix includes selecting a tissue matrix in the form of a flexible sheet.
Mammary prostheses · CPC title
Nose parts · CPC title
characterised by physical conditions of the treatment, e.g. applying a compressive force to the composition, pressure cycles, ultrasonic/sonication or microwave treatment, lyophilisation · CPC title
Collagen · CPC title
for mammary reconstruction · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.